Stocks and InvestingStocks and Investing
Mon, October 26, 2020
Fri, October 23, 2020
Thu, October 22, 2020
Wed, October 21, 2020

Rick Wise Maintained (ABT) at Strong Buy with Increased Target to $120 on, Oct 21st, 2020


Published on 2024-10-27 14:26:46 - WOPRAI, Rick Wise
  Print publication without navigation


Rick Wise of Stifel, Maintained "Abbott Laboratories" (ABT) at Strong Buy with Increased Target from $115 to $120 on, Oct 21st, 2020.

Rick has made no other calls on ABT in the last 4 months.



There are 10 other peers that have a rating on ABT. Out of the 10 peers that are also analyzing ABT, 1 agrees with Rick's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Danielle Antalffy of "SVB Leerink" Maintained at Hold with Increased Target to $110 on, Friday, July 17th, 2020


These are the ratings of the 9 analyists that currently disagree with Rick


  • Joshua Jennings of "TD Cowen" Maintained at Buy with Decreased Target to $113 on, Monday, October 19th, 2020
  • Robbie Marcus of "JP Morgan" Maintained at Buy with Increased Target to $125 on, Friday, October 9th, 2020
  • Mike Polark of "Wolfe Research" Initiated at Buy and Held Target at $124 on, Friday, September 11th, 2020
  • Matt Miksic of "Credit Suisse" Maintained at Buy with Increased Target to $136 on, Monday, August 31st, 2020
  • Joanne Wuensch of "Citigroup" Maintained at Strong Buy with Increased Target to $130 on, Friday, August 28th, 2020
  • David Lewis of "Morgan Stanley" Maintained at Buy with Increased Target to $112 on, Thursday, August 27th, 2020
  • Larry Biegelsen of "Wells Fargo" Maintained at Buy with Increased Target to $115 on, Thursday, August 27th, 2020
  • David Toung of "Argus Research" Maintained at Strong Buy with Increased Target to $125 on, Thursday, July 23rd, 2020
  • John Sourbeer of "UBS" Maintained at Strong Buy with Increased Target to $110 on, Friday, July 17th, 2020